Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections

Over the past decade, intravitreal injections of anti-VEGF agents have been widely used and intensively developed as a treatment option for many ophthalmological indications. Due to its availability and low cost, the most frequently used anti-VEGF agent is bevacizumab. This type of therapy is often...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Andrijana Kopić, Dubravka Biuk, Josip Barać, Maja Vinković, Tvrtka Benašić, Vlatko Kopić
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2017-01-01
Edice:	Acta Clinica Croatica
Témata:	Vascular endothelial growth factor A Bevacizumab Retinal degeneration Macular edema Diabetes mellitus Glaucoma, primary open angle
On-line přístup:	https://hrcak.srce.hr/file/282145
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!